Literature DB >> 3001110

Regulation of the epidermal growth factor receptor by phosphorylation.

P J Bertics, W Weber, C Cochet, G N Gill.   

Abstract

The receptor for epidermal growth factor (EGF) is a glycosylated transmembrane phosphoprotein that exhibits EGF-stimulable protein tyrosine kinase activity. On EGF stimulation, the receptor undergoes a self-phosphorylation reaction at tyrosine residues located primarily in the extreme carboxyl-terminal region of the protein. Using enzymatically active EGF receptor purified by immunoaffinity chromatography from A431 human epidermoid carcinoma cells, the self-phosphorylation reaction has been characterized as a rapid, intramolecular process which is maximal at 30-37 degrees C and exhibits a very low Km for ATP (0.2 microM). When phosphorylation of exogenous peptide substrates was measured as a function of receptor self-phosphorylation, tyrosine kinase activity was found to be enhanced two to threefold at 1-2 mol of phosphate per mol of receptor. Analysis of the dependence of the tyrosine kinase activity on ATP concentration yielded hyperbolic kinetics when plotted in double-reciprocal fashion, indicating that ATP can serve as an activator of the enzyme. Higher concentrations of peptide substrates were found to inhibit both the self- and peptide phosphorylation, but this inhibition could be overcome by first self-phosphorylating the enzyme. These results suggest that self-phosphorylation can remove a competitive/inhibitory constraint so that certain exogenous substrates can have greater access to the enzyme active site. In addition to self-phosphorylation, the EGF receptor can be phosphorylated on threonine residues by the calcium- and phospholipid-dependent protein kinase C. The sites on the EGF receptor phosphorylated in vitro by protein kinase C are identical to the sites phosphorylated on the receptor isolated from A431 cells exposed to the tumor promoters 12-O-tetradecanoylphorbol 13-acetate or teleocidin. This phosphorylation of the EGF receptor results in a suppression of its tyrosine kinase and EGF binding activities both in vivo and in vitro. The EGF receptor can thus be variably regulated by phosphorylation: self-phosphorylation can enhance tyrosine kinase activity whereas protein kinase C-catalyzed phosphorylation can depress enzyme activity. Because these two phosphorylations account for only a fraction of the phosphate present in the EGF receptor in vivo, other protein kinases can apparently phosphorylate the receptor and these may exert additional controls on EGF receptor/kinase function.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3001110     DOI: 10.1002/jcb.240290304

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Phorbol ester treatment stimulates tyrosine phosphorylation of a sea urchin egg cortex protein.

Authors:  W P Jiang; R A Gottlieb; W J Lennarz; W H Kinsey
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

2.  Differential protein phosphorylation in induction of thyroid cell proliferation by thyrotropin, epidermal growth factor, or phorbol ester.

Authors:  L Contor; F Lamy; R Lecocq; P P Roger; J E Dumont
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

Review 3.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

4.  Differential effects of carboxy-terminal sequence deletions on platelet-derived growth factor receptor signaling activities and interactions with cellular substrates.

Authors:  K Seedorf; B Millauer; G Kostka; J Schlessinger; A Ullrich
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 5.  Receptor tyrosine kinases: legacy of the first two decades.

Authors:  Joseph Schlessinger
Journal:  Cold Spring Harb Perspect Biol       Date:  2014-03-01       Impact factor: 10.005

6.  Tissue-specific transformation by epidermal growth factor receptor: a single point mutation within the ATP-binding pocket of the erbB product increases its intrinsic kinase activity and activates its sarcomagenic potential.

Authors:  H K Shu; R J Pelley; H J Kung
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

7.  Biochemical basis for the functional switch that regulates hepatocyte growth factor receptor tyrosine kinase activation.

Authors:  Payal R Sheth; John L Hays; Lisa A Elferink; Stanley J Watowich
Journal:  Biochemistry       Date:  2008-03-07       Impact factor: 3.162

Review 8.  Expanding the Disorder-Function Paradigm in the C-Terminal Tails of Erbbs.

Authors:  Louise Pinet; Nadine Assrir; Carine van Heijenoort
Journal:  Biomolecules       Date:  2021-11-14

9.  Prognostic Role of Combined EGFR and Tumor-Infiltrating Lymphocytes in Oral Squamous Cell Carcinoma.

Authors:  Wattawan Wongpattaraworakul; Katherine N Gibson-Corley; Allen Choi; Marisa R Buchakjian; Emily A Lanzel; Anand Rajan Kd; Andrean L Simons
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

10.  Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites.

Authors:  A Honegger; T J Dull; F Bellot; E Van Obberghen; D Szapary; A Schmidt; A Ullrich; J Schlessinger
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.